111 related articles for article (PubMed ID: 28684410)
1. Novel Mitochondrial Mechanisms of Cytarabine Resistance in Primary AML Cells.
Schimmer AD
Cancer Discov; 2017 Jul; 7(7):670-672. PubMed ID: 28684410
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.
Farge T; Saland E; de Toni F; Aroua N; Hosseini M; Perry R; Bosc C; Sugita M; Stuani L; Fraisse M; Scotland S; Larrue C; Boutzen H; Féliu V; Nicolau-Travers ML; Cassant-Sourdy S; Broin N; David M; Serhan N; Sarry A; Tavitian S; Kaoma T; Vallar L; Iacovoni J; Linares LK; Montersino C; Castellano R; Griessinger E; Collette Y; Duchamp O; Barreira Y; Hirsch P; Palama T; Gales L; Delhommeau F; Garmy-Susini BH; Portais JC; Vergez F; Selak M; Danet-Desnoyers G; Carroll M; Récher C; Sarry JE
Cancer Discov; 2017 Jul; 7(7):716-735. PubMed ID: 28416471
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.
Ma J; Liu B; Yu D; Zuo Y; Cai R; Yang J; Cheng J
Br J Haematol; 2019 Oct; 187(1):49-64. PubMed ID: 31236919
[TBL] [Abstract][Full Text] [Related]
4. Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia.
Aroua N; Boet E; Ghisi M; Nicolau-Travers ML; Saland E; Gwilliam R; de Toni F; Hosseini M; Mouchel PL; Farge T; Bosc C; Stuani L; Sabatier M; Mazed F; Larrue C; Jarrou L; Gandarillas S; Bardotti M; Picard M; Syrykh C; Laurent C; Gotanègre M; Bonnefoy N; Bellvert F; Portais JC; Nicot N; Azuaje F; Kaoma T; Joffre C; Tamburini J; Récher C; Vergez F; Sarry JE
Cancer Discov; 2020 Oct; 10(10):1544-1565. PubMed ID: 32641297
[TBL] [Abstract][Full Text] [Related]
5. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
6. The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia.
Yehudai D; Liyanage SU; Hurren R; Rizoska B; Albertella M; Gronda M; Jeyaraju DV; Wang X; Barghout SH; MacLean N; Siriwardena TP; Jitkova Y; Targett-Adams P; Schimmer AD
Haematologica; 2019 May; 104(5):963-972. PubMed ID: 30573504
[TBL] [Abstract][Full Text] [Related]
7. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
[TBL] [Abstract][Full Text] [Related]
8. Oxidative phosphorylation inhibition induces anticancerous changes in therapy-resistant-acute myeloid leukemia patient cells.
Vitkevičienė A; Janulis V; Žučenka A; Borutinskaitė V; Kaupinis A; Valius M; Griškevičius L; Navakauskienė R
Mol Carcinog; 2019 Nov; 58(11):2008-2016. PubMed ID: 31385375
[TBL] [Abstract][Full Text] [Related]
9. Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.
Macanas-Pirard P; Broekhuizen R; González A; Oyanadel C; Ernst D; García P; Montecinos VP; Court F; Ocqueteau M; Ramirez P; Nervi B
Oncotarget; 2017 Apr; 8(14):23073-23086. PubMed ID: 28160570
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML.
Malani D; Murumägi A; Yadav B; Kontro M; Eldfors S; Kumar A; Karjalainen R; Majumder MM; Ojamies P; Pemovska T; Wennerberg K; Heckman C; Porkka K; Wolf M; Aittokallio T; Kallioniemi O
Leukemia; 2017 May; 31(5):1187-1195. PubMed ID: 27833094
[TBL] [Abstract][Full Text] [Related]
11. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia.
Gaur T; Ali A; Sharma D; Gupta SK; Gota V; Bagal B; Platzbeckar U; Mishra R; Dutt A; Khattry N; Mills K; Hassan MI; Sandur S; Hasan SK
Cell Signal; 2024 Feb; 114():111004. PubMed ID: 38048856
[TBL] [Abstract][Full Text] [Related]
12. AHR signaling pathway mediates mitochondrial oxidative phosphorylation which leads to cytarabine resistance.
Jia Y; Li X; Chen L; Li L; Zhang S; Huang W; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):597-606. PubMed ID: 38404179
[TBL] [Abstract][Full Text] [Related]
13. Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells.
You R; Wang B; Chen P; Zheng X; Hou D; Wang X; Zhang B; Chen L; Li D; Lin X; Huang H
Cancer Lett; 2022 Apr; 532():215582. PubMed ID: 35122876
[TBL] [Abstract][Full Text] [Related]
14. Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine.
Yucel B; Sonmez M
Hematology; 2018 Jul; 23(6):330-336. PubMed ID: 29139328
[TBL] [Abstract][Full Text] [Related]
15. Targeting mitochondrial RNA polymerase in acute myeloid leukemia.
Bralha FN; Liyanage SU; Hurren R; Wang X; Son MH; Fung TA; Chingcuanco FB; Tung AY; Andreazza AC; Psarianos P; Schimmer AD; Salmena L; Laposa RR
Oncotarget; 2015 Nov; 6(35):37216-28. PubMed ID: 26484416
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
[TBL] [Abstract][Full Text] [Related]
17. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia.
Henkenius K; Greene BH; Barckhausen C; Hartmann R; Märken M; Kaiser T; Rehberger M; Metzelder SK; Parak WJ; Neubauer A; Brendel C; Mack E
Leuk Res; 2017 Nov; 62():56-63. PubMed ID: 28985623
[TBL] [Abstract][Full Text] [Related]
19. Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening.
Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M
Tissue Eng Part C Methods; 2017 Feb; 23(2):72-85. PubMed ID: 28007011
[TBL] [Abstract][Full Text] [Related]
20. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
